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Letters to the Editorwith type 2 dia
To the Editor:
Immonen et al. conducted a 6-month follow-up study to assess
the effects of bariatric surgery on hepatic insulin sensitivity [1].
The authors concluded that bariatric surgery showed signiﬁcant
improvement in hepatic insulin sensitivity, expressed by
insulin-stimulated hepatic glucose uptake and lowering of
endogenous glucose production, in combination with a marked
reduction in hepatic volume and fat content in 14 non-diabetic
patients and in 9 diabetic patients. In addition, there was no
remarkable difference regarding the gain in hepatic insulin sensi-
tivity between data from non-diabetic patients and diabetic
patients.
Mingrone et al. conducted a randomized, controlled trial to
evaluate the advantage of bariatric surgery without medical ther-
apy vs. conventional medical therapy for type 2 diabetes mellitus
[2]. The authors examined the data 2 years later, and bariatric
surgery resulted in better glucose control than did medical ther-
apy in severely obese patients, deﬁned by a body mass index
(BMI) of 35 or higher at baseline, with type 2 diabetes mellitus.
In addition, BMI at baseline and the level of weight loss after
2-years did not relate to the improvement in hyperglycemia.
Schauer et al. reported that intensive medical therapy plus
bariatric surgery (MS therapy) achieved a more desirable glyce-
mic control than medical therapy alone (M therapy) after 3 years
in obese patients with uncontrolled type 2 diabetes mellitus [3],
and where the survey had been continued for the same popula-
tion [4,5]. The authors included baseline subjects with a BMI of
27 to 43 and presented a sub-analysis by splitting patients with
a body-mass index (BMI) below 35 or higher. As a result, the low-
ering effect of MS therapy for glycated haemoglobin against M
therapy was predominant in patients with a BMI of 35 or higher.
In contrast, there is a meta-analysis that shows that bariatric
surgery for the treatment of diabetes mellitus in patients with
BMI of less than 35 is highly effective, although there are very
few randomized trials [6,7].
In fact, the application of bariatric surgery for obese subjects
with metabolic disorder sometimes differs among different eth-
nic populations, and the choice of medical therapy has become
wider by the recent development in medical therapy. In addition,
metabolic components such as dyslipidemia, hypertension, dia-
betes mellitus and obesity correlate each other. Furthermore,
Courcoulas et al. recently reported that different types of bariatric
surgeries showed different effectiveness for the treatment of
type 2 diabetes mellitus [8], which has been reviewed by
Maggard-Gibbons et al. [7]. From these circumstances, many
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more randomized controlled studies are required to validate
the effect of bariatric surgery in obese patients with type 2
diabetes mellitus.
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